Paper: “A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?” By Dr. Helen Cross

Summary:

In this paper,  Dr. Helen Cross, warns about the risks of artisanal preparations, not only due to the impossibility to check the amount of CBD per flask and its stability but because of the risk of inconsistency or unknown constituents. Because of the characteristics and the elaboration of these flasks it is impossible to perform clinical studies to compare them with pharmaceutical products with GMP

1. J Helen Cross , Hannah Cock. A Perspective on Cannabinoids for Treating Epilepsy: Do They Really Change the Landscape? Neuropharmacology 2020 Jun 15;170:107861.

https://pubmed.ncbi.nlm.nih.gov/31770546/

Share:

Back